2) Breast cancer with lung metastasis/drug treatment 乳腺癌肺转移/药物疗法3) ADENOCARCINOMA/drug ther 腺癌/药物疗法4) breast neoplasms/drug therapy 乳腺肿瘤/药物疗法5) breast neoplasms/DT 乳腺肿瘤/药物疗法6) Breast Neoplasms/drug ther 乳腺肿瘤/药物疗法...
Drugs used after and in addition to surgery are calledadjuvant therapy(辅助治疗). Chemotherapy or other types of therapy prior to surgery are calledneoadjuvant therapy(新辅助治疗). There are currently three main groups of medica...
BREAST CANCER: THE LATEST EVIDENCES IN DRUG THERAPYK. TamuraAnnals of Oncology
For the first time, a drug targeting a protein that drives breast cancer growth has been shown to work against tumors with very low levels of the protein. It’s not a cure. But this latest gain for targeted cancer therapy could open new treatment possibilities to thousands of patients with ...
The majority of breast cancers express the estrogen receptor (ERα) and agents targeting this pathway represent the main treatment modality. Endocrine therapy has proven successful in the treatment of hormone-responsive breast cancer since its early adop
WASHINGTON, May 4 (Xinhua) -- Chinese researchers discovered that a widely-used osteoporosis drug might prevent the spread of a particular aggressive form of breast cancer that typically affects younger, premenopausal women. A study published on Friday in the Journal of Experimental Medicine revealed...
WASHINGTON, May 4 (Xinhua) -- Chinese researchers discovered that a widely-used osteoporosis drug might prevent the spread of a particular aggressive form of breast cancer that typically affects younger, premenopausal women. A study published on Friday in the Journal of Experimental Medicine revealed...
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies Article Open access 16 October 2020 Tumor biomarkers for diagnosis, prognosis and targeted therapy Article Open access 20 May 2024 Functional genomics for breast can...
Several clinical trials have demonstrated the effectiveness of Trop2-targeted therapy in breast cancer. Sacituzumab govitecan (SG) is a Trop2-targeted antibody-drug conjugate (ADC) that has been approved for the treatment of metastatic TNBC and hormone receptor-positive (HR+) and human epidermal...
During a Case-Based Roundtable® event, Ian Krop, MD, PhD, and event participants discussed how different types of metastases and treatment toxicity would affect therapy given to patients with triple-positive breast cancer in the second article of a 2-part series....